ArticleBMC oral health2026
Medical practitioners' awareness and practices regarding bisphosphonate therapy and oral health risks: a Malaysian cross‑sectional study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundBisphosphonates are widely prescribed for osteoporosis, Paget's disease, and malignancy-related bone disease. While effective in reducing skeletal complications, they are associated with medication-related osteonecrosis of the jaw (MRONJ), a serious but preventable condition. Medical practitioners play a central role in initiating therapy, educating patients, and coordinating referrals, yet data on awareness and practices in Malaysia remain limited.
objectiveThis study assessed the awareness, prescribing practices, and perceived roles of medical practitioners at a university hospital concerning oral health risks associated with bisphosphonate therapy.
methodsA cross-sectional survey was conducted among 130 medical practitioners at a university hospital using a validated questionnaire. Participants included medical officers, Clinical Master's trainees, and specialists in medicine, orthopaedics, and primary care. The questionnaire assessed demographics, awareness of oral complications, prescribing patterns, referral behaviours, and perceived roles. Data were analysed using descriptive statistics and chi-square tests.
resultsMost respondents (96.2%) were aware that bisphosphonates may cause oral complications, and 94.6% identified MRONJ. However, only 58.5% reported awareness of clinical guidelines, and 23.8% felt adequately informed to manage affected patients. Oral bisphosphonates were the most frequently prescribed (77.7%), primarily for osteoporosis (95.4%), while intravenous forms were less common; at osteoporosis dosing, the risk of MRONJ with intravenous zoledronate remains very low compared to oncology regimens. Alternative therapies were considered by 67.7% of practitioners, most often denosumab and teriparatide. Preventive practices were inconsistent: 73.8% educated patients about MRONJ, 49.2% advised pretreatment dental evaluation, and 52.3% referred patients for dental screening. Awareness was significantly associated with prescribing frequency, while referral behaviours varied by department, position, and age.
conclusionMedical practitioners demonstrated high recognition awareness of MRONJ but notable gaps in guideline literacy, preventive practices, and interprofessional collaboration. These findings highlight the need for structured education, clearer referral protocols, and stronger integration between medical and dental teams to ensure early prevention and optimal patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.